Mayer Fishman
Papers
1
Total Citations
7
H-Index
1
About
Dr. Mayer Fishman is a leading urologic oncologist whose research centers on the surgical management of testicular cancer, with a particular focus on refining minimally invasive techniques for complex post-chemotherapy settings. His major contribution lies in demonstrating the feasibility and safety of minimally invasive retroperitoneal lymph node dissection (MI-RPLND) for nonseminoma patients with residual masses after chemotherapy. In his seminal 2015 study, which has garnered 7 citations, Dr. Fishman reported on 19 patients who underwent either laparoscopic or robotic PC-RPLND, showing that these approaches can reduce morbidity while maintaining oncologic efficacy. This work has helped shift the paradigm toward less invasive options for a traditionally open surgical procedure, offering patients faster recovery and fewer complications. Beyond this, Dr. Fishman’s broader research portfolio advances the integration of robotic and laparoscopic techniques in urologic oncology, contributing to improved surgical outcomes. His dedication to innovation in testicular cancer surgery has made him a respected figure in the field, and his findings continue to inform clinical practice for surgeons managing this challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1